p53 Suppressor Activation in Recurrent High Grade Serous Ovarian Cancer, a Phase Ib/II Study of Systemic Carboplatin Combination Chemotherapy With or Without APR-246

Institut Jules Bordet, Brussels

Antwerp University Hospital, Antwerp

Medische oncologie, Universitair Ziekenhuis Gent, Ghent

Praxisklinik, Krebsheilkunde für Frauen, Berlin

Charité Campus Virchow-Klinikum, Berlin

Hospital Universitario Reina Sofia, Córdoba

UPMC Hillman Cancer Center, Magee-Womens Hospital, Pittsburgh

The University of Pennsylvania, Philadelphia

Fox Chase Cancer Center, Philadelphia

Universitätsklinikum Hamburg-Eppendorf, Hamburg

Massey Cancer Center, Virginia Commonwealth University, Richmond

Centro Oncologico MD Anderson, Madrid

Hospital Universitario Ramón y Cajal, Madrid

Hospital Universitario Fundación Jiménez Díaz, Madrid

Hospital Universitario HM Sanchinarro, Madrid

Hospital Universitario Virgen de la Victoria, Málaga

Vanderbilt University Medical Center, Nashville

Centre Catherine de Sienne, Nantes

Hospital Clinico Universitario de Valencia, Valencia

Barbara Ann Karmanos Cancer Institute, Detroit

Hospital Clínico Universitario Lozano Blesa, Zaragoza

University of Chicago, Chicago

Centre Paul Strass, Strasbourg

Centre Léon Bérard, Lyon

Centre Hospitalier Lyon Sud, Lyon

Institut Curie, Paris

Hôpital des Diaconesses (Site Reuilly), Paris

Parkland, UT Southwestern Medical Center, Dallas

University of Texas Southwestern Medical Center, Dallas

The University of Texas MD Anderson Cancer Center, Houston

Universitätsfrauenklinik Ulm, Ulm

UCLA, Los Angeles

Institut Gustave Roussy, Villejuif

Oregon Health & Science University, Portland

Swedish Cancer Institute, Seattle

Massachusetts General Hospital, Boston

Dana Farber Cancer Institute, Boston

Cliniques Universitaires Saint Luc, Brussels

Leuven University Hospitals, Leuven

Universitätsklinikum Carl Gustav Carus, Dresden

Academisch Medisch Centrum, Amsterdam

Universitair Medisch Centrum Groningen, Groningen

Leids Universitair Medisch Centrum, Leiden

Academisch Ziekenhuis Maastricht, Maastricht

Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Badalona

Hospital Vall d'Hebron, Barcelona

Hospital Universitario Araba, Vitoria-Gasteiz

Karolinska University Hospital, Stockholm

Bristol Haematology & Oncology Centre, University Hospitals Bristol, Bristol

Cambridge Cancer Trials Centre, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge

Edinburgh Cancer Research Centre, The University of Edinburgh, Edinburgh

The Clatterbridge Cancer Center NHS Foundation Trust, Liverpool

The Royal Marsden NHS Foundation Trust, London

Imperial College London, Hammersmith Hospital Campus, London

The Christie NHS Foundation Trust, Manchester